Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 21, 2015; 21(7): 2159-2168
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2159
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2159
Figure 3 Kaplan-Meier estimates of disease specific survival for patients with gastric cancer according to the mismatch repair (A) and ARID1A expression (B) statuses.
The disease specific survival curves according to the MMR and ARID1A expression statuses did not show significant differences. 1The log-rank test. MST: Median survival time; MMR: Mismatch repair.
- Citation: Inada R, Sekine S, Taniguchi H, Tsuda H, Katai H, Fujiwara T, Kushima R. ARID1A expression in gastric adenocarcinoma: Clinicopathological significance and correlation with DNA mismatch repair status. World J Gastroenterol 2015; 21(7): 2159-2168
- URL: https://www.wjgnet.com/1007-9327/full/v21/i7/2159.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i7.2159